Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2011
August 2011, Vol 2, No 5
August 2011, Vol 2, No 5
New Molecular Test Approved to Detect HER2 in Women with Breast Cancer
FDA Approvals, News & Updates
August 2011, Vol 2, No 5
Read Article
Novel Nasal Spray Formulation of Fentanyl Citrate for Cancer Pain
FDA Approvals, News & Updates
August 2011, Vol 2, No 5
Read Article
Benchmarks for Measuring the Success of a Medical Home in Oncology
By
Robert Gamble
;
Mary Kruczynski
Cancer Care
,
Personalized Medicine
August 2011, Vol 2, No 5
As we move forward in the scheme of healthcare reform, we are being directed toward an integrated care model, one with high quality and economic efficiency. Recently, a model known as an accountable care organization (ACO) was introduced by the US Department of Health and Human Services in the form of a proposed rule open for public comment.
Read Article
Patients with Cancer at Risk for Bankruptcy
By
Caroline Helwick
ASCO Annual Meeting
August 2011, Vol 2, No 5
Chicago, IL—Nearly 2% of patients with cancermay file for personal bankruptcy 5 years after their diagnosis, according to researchers from Fred Hutchinson Cancer Research Center in Seattle who presented their data at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting.
Read Article
Upper GI Cancers: Are We Getting Value for the Money?
By
Audrey Andrews
ASCO Annual Meeting
August 2011, Vol 2, No 5
Upper GI Malignancies” was a plenary session at ASCO 2011, with 2 experts discussing whether results of recent clinical trials of targeted agents are clinically meaningful or just statistically positive, and what is the value of the enormous amount of money spent in treating noncolorectal gastrointestinal (GI) cancer.
Read Article
Northwestern University Comprehensive Cancer Center
Oncology
August 2011, Vol 2, No 5
Interview with Al B. Benson III, MD, FACP,
Professor of Medicine and Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
Read Article
Post-ASCO Survey: Oncologists’ and Payers’ Treatment and Coverage Decisions
By
Caroline Helwick
Reimbursement
August 2011, Vol 2, No 5
An analysis of payer and provider responses to key clinical information presented at the ASCO 2011 annual meeting offers a glimpse of the oncology landscape shared by oncologists and health plans.
Read Article
Page 4 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma